𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Zuclopenthixol and thioridazine in the treatment of aggressive, elderly patients: A double-blind, controlled, multicentre study

✍ Scribed by A. Harenko; I. Alanen; S. Elovaara; S. Ginström; U. Hagert; M. Savijärvi; A. Yli-kerttula; K. Elgen


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
441 KB
Volume
7
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

✦ Synopsis


A four-week double-blind study of zuclopenthixol and thioridazine in 64 elderly patients presenting with hostility or restlessness has been carried out in five Finnish mental hospitals. The ages of the patients in the two groups ranged from 64 to 97 years. The initial daily dose was 2-6 mg zuclopenthixol or 20-60 mg thioridazine. In week 4 the mean daily dose was 6.8 mg zuclopenthixol and 62 mg thioridazine. After one week of treatment the severity of illness was reduced significantly in the zuclopenthixol group and in both groups after two and four weeks.

The key symptom hostility showed significant improvement in both treatment groups after only one week of treatment. The other key symptom restlessness was also significantly improved in both groups. The only significant difference between the groups was a better effect on sleep disturbance with zuclopenthixol. Few side-effects were recorded in either group, and no serious effects on cardiovascular function were found. The study indicates that both zuclopenthixol and thioridazine are effective drugs in the treatment of elderly patients with symptoms such as hostility, aggressiveness and restlessness.


📜 SIMILAR VOLUMES


Double-blind controlled withdrawal of th
✍ D. J. Findlay; J. Sharma; J. McEwen; B. R. Ballinger; W. J. MaClennan; A. M. McH 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB 👁 1 views

Thirty-six female inpatients with a clinical diagnosis of senile dementia, Alzheimer type, were entered into a doubleblind withdrawal of their established thioridazine. Over a four-week period there were no significant differences between the two study groups in terms of cognitive function, behaviou

A sequential double-blind controlled stu
✍ John Tiller; Dr Kay Maguire; Brian Davies 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

Moclobemide was compared with mianserin in a double-blind controlled study in elderly depressed patients. Sequential analysis of 1 1 pairs of patients found no significant difference between the drugs at the week 8 analysis. Unpaired comparison of the 26 patients completing four weeks' treatment als

Hypericum treatment of mild–moderate dep
✍ E. Schrader; B. Meier; A. Brattström 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

A prospective, randomized, multicentre, double-blind placebo controlled study is described which compares the ecacy and tolerability of hypericum administered as a concentrated ethanolic extract of St John's wort (ZE117) to patients with mild±moderate depression (ICD-10; F 32 . 0 mild; F 32 . 1 mode

A randomized controlled double blind stu
✍ S. Brook; M. Berk; S. Selemani; J. Kolloori; I. Nzo 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 3 views

This study is a double blind randomized controlled trial comparing zuclopenthixol acetate to haloperidol administered parenterally initially and followed by oral medication for 28 days in the treatment of acute psychosis. The sample included 44 patients with schizophrenia, schizophreniform disorder

Venlafaxine versus nortriptyline in the
✍ Rob M. Kok; Willem A. Nolen; Thea J. Heeren 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

## Abstract ## Background The majority of the trials in the elderly are outpatient trials which excluded psychotic patients and patients with common comorbid physical disorders. Consequently information is lacking about the more complex cases of elderly depressed patients, as found in inpatient wa